Biotech entity
Every one of those 1 sits in a single category, fda-approval. Of the tracked stories, 1 of 1 also mention Drugs for Neglected Diseases initiative (DNDi), the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Acoziborole, all published on March 16, 2026.
Last mentioned: Mar 16, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, fda-approval. Of the tracked stories, 1 of 1 also mention Drugs for Neglected Diseases initiative (DNDi), the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Acoziborole, all published on March 16, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Acoziborole. Shared-story counts are live from our verified record — not editorial picks.
Acoziborole Rollout
The first single-dose oral cure begins deployment, enabling 'screen-and-treat' strategies.
Fexinidazole Approval
The first all-oral treatment is approved, requiring 10 days of pills taken with food.
NECT Launch
Nifurtimox-eflornithine combination therapy improves safety but requires complex intravenous administration.
Melarsoprol Introduced
Arsenic-based treatment becomes standard but carries a 5% mortality rate due to toxicity.
The introduction of acoziborole, the first single-dose oral treatment for Human African Trypanosomiasis (sleeping sickness), marks a pivotal shift in global health efforts. Developed through a non-profit partnership between DNDi and Sanofi, the drug offers a simplified path to disease elimination by 2030.
Acoziborole is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
